Hot Flashes
- 1 January 2001
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs & Aging
- Vol. 18 (8), 597-606
- https://doi.org/10.2165/00002512-200118080-00004
Abstract
Menopause, an event often accompanied by symptoms such as hot flashes, can have a significant impact on a woman’s quality of life. A majority of women will experience hot flashes at some point in their life, given a normal life span. Despite multiple theories, the exact pathophysiology of hot flashes is not yet known. Many types of treatment options exist for women with hot flashes, from hormonal and nonhormonal pharmacological therapies to nonpharmacological interventions. Choosing the best treatment option for specific women involves knowledge of the risks and benefits of each treatment. Hormones (estrogen and/or progesterone, or tibolone alone) are still the most effective option available, resulting in an 80 to 90% reduction in hot flashes. The best nonhormonal treatment to date is in the class of newer antidepressants that comprises various selective reuptake inhibitors; for example, venlafaxine provides about a 60% reduction in hot flashes. This article provides evidence-based information about available treatment options for hot flash management, with special consideration of populations such as breast cancer survivors.Keywords
This publication has 83 references indexed in Scilit:
- The menopauseThe Lancet, 1999
- Long-Term Compliance with Estrogen Replacement Therapy in Surgical Postmenopausal Women: Benefits to Bone and Analysis of Factors Associated with DiscontinuationMenopause, 1999
- Veralipride for Hot Flushes during Gonadotropin-Releasing Hormone Agonist TreatmentGynecologic and Obstetric Investigation, 1992
- High-Dose Medroxyprogesterone Acetate versus Oophorectomy as First-Line Therapy of Advanced Breast Cancer in Premenopausal PatientsOncology, 1991
- Megestrol acetate: Phase II study of a single daily administration in advanced breast cancerBreast Cancer Research and Treatment, 1990
- Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancerBreast Cancer Research and Treatment, 1990
- The menopausal hot flash: a procrustean bed of researchJournal of Advanced Nursing, 1989
- Veralipride versus conjugated oestrogens: A double-blind study in the management of menopausal hot flushesCurrent Medical Research and Opinion, 1984
- Prospective double-blind trial of synthetic steroid (Org OD 14) for preventing postmenopausal osteoporosis.BMJ, 1980
- A STUDY OF THE EFFECTIVENESS OF PROPRANOLOL IN MENOPAUSAL HOT FLUSHESBJOG: An International Journal of Obstetrics and Gynaecology, 1978